Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00626483
Brief Title: Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia (REGULATe)

First Submitted : February 28, 2008
First Submitted that Met QC Criteria : February 28, 2008
First Posted : February 29, 2008 (Estimate)

Last Update Submitted that Met QC Criteria : August 22, 2019
Last Update Posted : August 28, 2019